Update on Diabetic Cardiomyopathy: Inches Forward, Miles to Go
- 15 April 2012
- journal article
- Published by Springer Nature in Current Diabetes Reports
- Vol. 12 (3) , 305-313
Abstract
Diabetes causes cardiomyopathy, both directly and by potentiating the effect of its common comorbidities, coronary artery disease and hypertension, on its development. With the common and growing prevalence of diabetes worldwide, diabetic cardiomyopathy is a significant public health problem. Recent research identifies both mitochondrial dysfunction and epigenetic effects as newly recognized factors in the complex pathogenesis of diabetic cardiomyopathy. Diagnostically, specialized echocardiography techniques, cardiac magnetic resonance imaging, and serologic biomarkers all appear to have promise in detecting the early stages of diabetic cardiomyopathy. Research into treatments includes both traditional diabetes and heart failure therapies, but also explores the potential of newer metabolic and anti-inflammatory agents. These recent insights provide important additions to our knowledge about diabetic cardiomyopathy, but much remains unknown.Keywords
This publication has 53 references indexed in Scilit:
- Mitochondrial dysfunction in diabetic cardiomyopathyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic CardiomyopathyJACC, 2010
- Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategiesVascular Health and Risk Management, 2010
- Lack of effects of pioglitazone on cardiac function in patients with type 2 diabetes and evidence of left ventricular diastolic dysfunction: a tissue doppler imaging studyCardiovascular Diabetology, 2010
- Diabetic cardiomyopathy: mechanisms and therapeutic targetsDrug Discovery Today: Disease Mechanisms, 2010
- Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosisJournal of Molecular and Cellular Cardiology, 2010
- Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptidesCardiovascular Diabetology, 2010
- Usefulness of Mitral Annulus Velocity for the Early Detection of Left Ventricular Dysfunction in a Rat Model of Diabetic CardiomyopathyJournal of Cardiovascular Ultrasound, 2010
- Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategiesVascular Health and Risk Management, 2009
- Preclinical Systolic and Diastolic Dysfunction Assessed by Tissue Doppler Imaging is Associated With Elevated Plasma Pro-B-type Natriuretic Peptide ConcentrationsJournal of Cardiac Failure, 2009